TABLE 4.
A list of histone demethylase inhibitors under different phases of clinical trial and their indication.
Histone demethylase inhibitor | ||||
---|---|---|---|---|
Classification | Compounds | Structure | Clinical stage | References |
LSD1 inhibitors | Tranylcypromine analogue (GSK2879552) |
![]() |
Clinical | Kalin et al. (2018) |
Bizine |
![]() |
Preclinical | Kim et al. (2020) | |
PG11144 |
![]() |
Preclinical | Zhu et al. (2012) | |
Namoline |
![]() |
Preclinical | Sewry et al. (2019) | |
JmjC domain inhibitors | IOX1 |
![]() |
Preclinical | Hoyle et al. (2021) |
KDM6B |
![]() |
Preclinical | Basu Mallik et al. (2017) |